Reducing prostaglandin E₂ production to raise cancer immunogenicity

Santiago ZelenayCancer Inflammation and Immunity Group, Cancer Research UK Manchester Institute, The University of Manchester, Manchester, UKCorrespondence[email protected] [email protected]

Caetano Reis e SousaImmunobiology Laboratory, The Francis Crick Institute, Lincoln's Inn Fields Laboratory, 44 Lincoln's Inn Fields, London, UKCorrespondence[email protected] [email protected]

Article: e1123370 | Received 17 Nov 2015, Accepted 17 Nov 2015, Published online: 11 May 2016

Cite this article
https://doi.org/10.1080/2162402X.2015.1123370
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

Sharma P, Allison JP. Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential. Cell 2015; 161:205-14; PMID:25860605; http://dx.doi.org/10.1016/j.cell.2015.03.030
PubMed Web of Science ®Google Scholar
Zelenay S, van der Veen AG, Böttcher JP, Snelgrove KJ, Rogers N, Acton SE, Chakravarty P, Girotti MR, Marais R, Quezada SA et al. Cyclooxygenase-Dependent Tumor Growth through Evasion of Immunity. Cell 2015; 162(6):1257-70; PMID:26343581; http://dx.doi.org/10.1016/j.cell.2015.08.015
PubMed Web of Science ®Google Scholar
Schreiber RD, Old LJ, Smyth MJ. Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion. Science 2011; 331:1565-70; PMID:21436444; http://dx.doi.org/10.1126/science.1203486
PubMed Web of Science ®Google Scholar
Zelenay S, Reis e Sousa C. Adaptive immunity after cell death. Trends Immunol 2013; 34:329-35; PMID:23608152; http://dx.doi.org/10.1016/j.it.2013.03.005
PubMed Web of Science ®Google Scholar
Matsushita H, Vesely MD, Koboldt DC, Rickert CG, Uppaluri R, Magrini VJ, Arthur CD, White JM, Chen Y-S, Shea LK et al. Cancer exome analysis reveals a T-cell-dependent mechanism of csancer immunoediting. Nature 2012; 482:400-4; PMID:22318521; http://dx.doi.org/10.1038/nature10755
Web of Science ®Google Scholar
DuPage M, Mazumdar C, Schmidt LM, Cheung AF, Jacks T. Expression of tumour-specific antigens underlies cancer immunoediting. Nature 2012; 482:405-9; PMID:22318517; http://dx.doi.org/10.1038/nature10803
PubMed Web of Science ®Google Scholar
Rooney MS, Shukla SA, Wu CJ, Getz G, Hacohen N. Molecular and genetic properties of tumors associated with local immune cytolytic activity. Cell 2015; 160:48-61; PMID:25594174; http://dx.doi.org/10.1016/j.cell.2014.12.033
PubMed Web of Science ®Google Scholar
Dhomen N, Reis-Filho JS, da Rocha Dias S, Hayward R, Savage K, Delmas V, Larue L, Pritchard C, Marais R. Oncogenic Braf Induces Melanocyte Senescence and Melanoma in Mice. Cancer Cell 2009; 15:294-303; PMID:19345328; http://dx.doi.org/10.1016/j.ccr.2009.02.022
PubMed Web of Science ®Google Scholar
Wang D, Dubois RN. Eicosanoids and cancer. Nature Rev Cancer 2010; 10:181-93; PMID:20168319; http://dx.doi.org/10.1038/nrc2809
PubMed Web of Science ®Google Scholar
http://www.cancerresearchuk.org/about-us/cancer-news/press-release/2015-10-22-worlds-largest-clinical-trial-on-aspirin-to-stop-cancer-returning-launches-today
Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Reducing prostaglandin E₂ production to raise cancer immunogenicity

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Reducing prostaglandin E2 production to raise cancer immunogenicity

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Reducing prostaglandin E₂ production to raise cancer immunogenicity